These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27380787)

  • 41. [Antabus treatment in general practice. A pharmaco-epidemiological study of prescription patterns based on a prescription database].
    Larsen J; Bjerrum L; Hallas J; Kragstrup J
    Ugeskr Laeger; 1998 Jun; 160(24):3544-7. PubMed ID: 9641040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Usefulness of disulfiram implants in the treatment of alcoholics].
    Koślacz A; Chabrowska-Popławska R
    Psychiatr Pol; 1984; 18(1):17-22. PubMed ID: 6739606
    [No Abstract]   [Full Text] [Related]  

  • 43. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors associated with compliance of alcoholics in outpatient treatment.
    Nielsen B; Nielsen AS; Wraae O
    J Nerv Ment Dis; 2000 Feb; 188(2):101-7. PubMed ID: 10695838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Academic doctors' views of complementary and alternative medicine (CAM) and its role within the NHS: an exploratory qualitative study.
    Maha N; Shaw A
    BMC Complement Altern Med; 2007 May; 7():17. PubMed ID: 17537248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of toxicity from concomitant directly observed disulfiram and isoniazid-containing therapy for active tuberculosis.
    Burman WJ; Terra M; Breese P; Cohn D; Reves R
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):839-42. PubMed ID: 12234141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Increased efficacy of teturam combined with L-DOPA in experimental alcoholism in the rat].
    Gromova EA; Khesin II; Bobkova NV; Plakkhinas LA; Tokareva AE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(8):1226-31. PubMed ID: 3022507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experienced acetaldehyde reaction does not improve treatment response in outpatients treated with supervised disulfiram.
    Mutschler J; Dirican G; Funke S; Obermann C; Grosshans M; Mann K; Kiefer F; Diehl A
    Clin Neuropharmacol; 2011; 34(4):161-5. PubMed ID: 21677573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orally elicited allergic contact dermatitis to tetraethylthiuramdisulfide.
    Gutgesell C; Fuchs T
    Am J Contact Dermat; 2001 Dec; 12(4):235-6. PubMed ID: 11783429
    [No Abstract]   [Full Text] [Related]  

  • 50. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tolerance to disulfiram induced by chronic alcohol intake in the rat.
    Tampier L; Quintanilla ME; Israel Y
    Alcohol Clin Exp Res; 2008 Jun; 32(6):937-41. PubMed ID: 18445101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disulfiram impairs the development of behavioural sensitization to the stimulant effect of ethanol.
    Kim AK; Souza-Formigoni ML
    Behav Brain Res; 2010 Mar; 207(2):441-6. PubMed ID: 19891992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial.
    Yoshimura A; Kimura M; Nakayama H; Matsui T; Okudaira F; Akazawa S; Ohkawara M; Cho T; Kono Y; Hashimoto K; Kumagai M; Sahashi Y; Roh S; Higuchi S
    Alcohol Clin Exp Res; 2014 Feb; 38(2):572-8. PubMed ID: 24117666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C in alcohol dependence:drinking versus disulfiram.
    Kulig CC; Beresford TP
    J Addict Dis; 2005; 24(2):77-89. PubMed ID: 15784525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disulfiram acceptors and refusers: do they differ?
    O'Neil PM; Roitzsch JC; Giacinto JP; Miller WC
    Addict Behav; 1982; 7(2):207-9. PubMed ID: 7102454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depot preparations of disulfiram: experimental and clinical results.
    Johnsen J; Mørland J
    Acta Psychiatr Scand Suppl; 1992; 369():27-30. PubMed ID: 1471548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subacute vocal cord paralysis, facial palsy and paraesthesias of lower limbs following surreptitious administration of disulfiram.
    Manjunatha N; Vidyendaran R; Rao MG; Kulkarni GB; Muralidharan K; John JP; Amar BR; Jain S
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1409-10. PubMed ID: 20562393
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute encephalopathy and polyneuropathy after disulfiram intoxication.
    Zorzon M; Masè G; Biasutti E; Vitrani B; Cazzato G
    Alcohol Alcohol; 1995 Sep; 30(5):629-31. PubMed ID: 8554646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acceptance of pharmacotherapy for relapse prevention by chronic alcoholics.
    Wetterling T; Veltrup C; Junghanns K; Krömer-Olbrisch T; Schneider U
    Pharmacopsychiatry; 2001 Jul; 34(4):142-6. PubMed ID: 11518475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Reversible optic neuropathy related to disulfiram].
    Trélohan A; Milea D
    J Fr Ophtalmol; 2011 Jun; 34(6):382.e1-3. PubMed ID: 21507508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.